| Bioactivity | SC-50605 and SC-51146 are second-generation leukotriene B4 (LTB4) receptor antagonists that potently inhibit LTB4-induced chemotaxis in guinea pigs. SC-50605 targets the LTB4 receptor and has potential for inhibiting inflammatory diseases such as asthma, rheumatoid arthritis and skin diseases[1]. |
| Target | LTB4 |
| CAS | 174514-07-9 |
| Formula | C15H12BrClF4N2O2 |
| Molar Mass | 443.62 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Fluazolate
CAS: 174514-07-9 F: C15H12BrClF4N2O2 W: 443.62
SC-50605 and SC-51146 are second-generation leukotriene B4 (LTB4) receptor antagonists that potently inhibit LTB4-induce
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.